{"id":"W4305015938","doi":"10.1038/s41591-022-02015-7","title":"Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial","year":2022,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Irving Medical Center, Columbia University; National Cancer Institute; University of Toronto; Cancer Center, University of Colorado; Weill Cornell Medical College; University of Oklahoma; Centro de Investigación Biomédica en Red de Cáncer; Stephenson Cancer Center; Vanderbilt University Medical Center; Cedars-Sinai Medical Center; University of Pittsburgh; Vanderbilt-Ingram Cancer Center; Memorial Sloan-Kettering Cancer Center; Vanderbilt University","keywords":"Medicine; Clinical endpoint; Melanoma; Internal medicine; Rash; Adverse effect; Clinical trial; Oncology; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Survival rate; Surrogate endpoint; Progression-free survival; Surgery; Gastroenterology; Overall survival; Cancer research","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001556847,0.0009674969,0.001116776,0.0003112149,0.0002655749,0.0005333732,0.0004925625,0.00113254,0.002153987],"category_scores_gemma":[0.0007738158,0.0002834763,0.0009583082,0.0002632386,0.0005454572,0.0004749129,0.0002329266,0.001688343,0.0004454337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005198985,"about_ca_system_score_gemma":0.0007187791,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006043136,"about_ca_topic_score_gemma":0.001972091,"domain_scores_codex":[0.9996358,0.0002030291,0.0000156276,0.0000493824,0.00003537861,0.0000608005],"domain_scores_gemma":[0.9995447,0.00008321534,0.0001028078,0.0000285205,0.00002395084,0.000216764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6109291,0.04605649,0.01857091,0.001398963,0.002234676,0.00101741,0.0004270167,0.004131112,0.09657866,0.0004019171,0.005038115,0.2132156],"study_design_scores_gemma":[0.5229792,0.4252808,0.03908177,0.00007625631,0.0005557469,0.0008620972,0.00006019762,0.002423688,0.004864941,0.0002493631,0.003525932,0.00003997022],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945847,0.002607703,0.0002875745,0.0002543037,0.00004983536,0.0007747521,0.0003839436,0.00005219051,0.001004919],"genre_scores_gemma":[0.9917978,0.002072216,0.0009699074,0.0006564024,0.0001389944,0.001283169,0.001480835,0.00001562091,0.00158506],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002153987,"threshold_uncertainty_score":0.008233488,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0131082228485558,"score_gpt":0.3671599209829994,"score_spread":0.3540516981344436,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}